Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Early stopping of randomized clinical trials for overt efficacy is problematic.

Bassler D, Montori VM, Briel M, Glasziou P, Guyatt G.

J Clin Epidemiol. 2008 Mar;61(3):241-6. doi: 10.1016/j.jclinepi.2007.07.016. Review.

PMID:
18226746
2.

Randomized trials stopped early for benefit: a systematic review.

Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH.

JAMA. 2005 Nov 2;294(17):2203-9. Review.

PMID:
16264162
3.

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.

Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH; STOPIT-2 Study Group., Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schünemann H, Cook DJ, Lutz K, Ribic CM, Vale N, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Bucher HC, Nordmann AJ, Raatz H, da Silva SA, Tuche F, Strahm B, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Karanicolas PJ, Burns KE, Vandvik PO, Coto-Yglesias F, Chrispim PP, Ramsay T.

JAMA. 2010 Mar 24;303(12):1180-7. doi: 10.1001/jama.2010.310. Review.

PMID:
20332404
4.

Randomized trials stopped early for harm in HIV/AIDS: a systematic survey.

Mills E, Cooper C, Wu P, Rachlis B, Singh S, Guyatt GH.

HIV Clin Trials. 2006 Jan-Feb;7(1):24-33. Review.

PMID:
16684642
5.

Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design.

Prutsky GJ, Domecq JP, Erwin PJ, Briel M, Montori VM, Akl EA, Meerpohl JJ, Bassler D, Schandelmaier S, Walter SD, Zhou Q, Coello PA, Moja L, Walter M, Thorlund K, Glasziou P, Kunz R, Ferreira-Gonzalez I, Busse J, Sun X, Kristiansen A, Kasenda B, Qasim-Agha O, Pagano G, Pardo-Hernandez H, Urrutia G, Murad MH, Guyatt G.

Trials. 2013 Oct 16;14:335. doi: 10.1186/1745-6215-14-335. Review.

6.

An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.

Stegert M, Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Briel M; DISCO study group..

J Clin Epidemiol. 2016 Jan;69:152-60. doi: 10.1016/j.jclinepi.2015.05.023. Review.

PMID:
26361993
7.

Systematic reviewers neglect bias that results from trials stopped early for benefit.

Bassler D, Ferreira-Gonzalez I, Briel M, Cook DJ, Devereaux PJ, Heels-Ansdell D, Kirpalani H, Meade MO, Montori VM, Rozenberg A, Schünemann HJ, Guyatt GH.

J Clin Epidemiol. 2007 Sep;60(9):869-73. Review.

PMID:
17689802
8.

Issues in data monitoring and interim analysis of trials.

Grant AM, Altman DG, Babiker AB, Campbell MK, Clemens FJ, Darbyshire JH, Elbourne DR, McLeer SK, Parmar MK, Pocock SJ, Spiegelhalter DJ, Sydes MR, Walker AE, Wallace SA; DAMOCLES study group..

Health Technol Assess. 2005 Mar;9(7):1-238, iii-iv. Review.

9.

Meta-analysis of clinical trials with early stopping: an investigation of potential bias.

Schou IM, Marschner IC.

Stat Med. 2013 Dec 10;32(28):4859-74. doi: 10.1002/sim.5893. Review.

PMID:
23824994
10.

Early stopping rules and long-term follow-up in phase III trials.

Pignon JP, Arriagada R.

Lung Cancer. 1994 Mar;10 Suppl 1:S151-9. Review.

PMID:
8087505
11.

Early stopping rules in oncology: considerations for clinicians.

Mukherjee SD, Goffin JR, Taylor V, Anderson KK, Pond GR.

Eur J Cancer. 2011 Nov;47(16):2381-6. doi: 10.1016/j.ejca.2011.05.019. Review.

PMID:
21684153
12.

Clinical trial design issues: at least 10 things you should look for in clinical trials.

Glasser SP, Howard G.

J Clin Pharmacol. 2006 Oct;46(10):1106-15. Review.

PMID:
16988199
13.

Challenges of cluster randomized trials.

Campbell MJ.

J Comp Eff Res. 2014 May;3(3):271-81. doi: 10.2217/cer.14.21. Review.

PMID:
24969154
14.

Data monitoring committees and interim monitoring guidelines.

Freidlin B, Korn EL, George SL.

Control Clin Trials. 1999 Oct;20(5):395-407. Review.

PMID:
10503800
15.

Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit.

Murad MH, Guyatt GH, Domecq JP, Vernooij RW, Erwin PJ, Meerpohl JJ, Prutsky GJ, Akl EA, Mueller K, Bassler D, Schandelmaier S, Walter SD, Busse JW, Kasenda B, Pagano G, Pardo-Hernandez H, Montori VM, Wang Z, Briel M.

J Clin Epidemiol. 2017 Feb;82:12-19. doi: 10.1016/j.jclinepi.2016.10.006. Review.

PMID:
27832953
16.

Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.

Ahmad S, Kew KM, Normansell R.

Cochrane Database Syst Rev. 2015 Jun 19;(6):CD011306. doi: 10.1002/14651858.CD011306.pub2. Review.

PMID:
26089258
17.

Trials in surgery.

Lilford R, Braunholtz D, Harris J, Gill T.

Br J Surg. 2004 Jan;91(1):6-16. Review.

PMID:
14716788
18.

Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.

Chen YF, Madan J, Welton N, Yahaya I, Aveyard P, Bauld L, Wang D, Fry-Smith A, Munafò MR.

Health Technol Assess. 2012;16(38):1-205, iii-v. doi: 10.3310/hta16380. Review.

19.

Ethanol for preventing preterm birth in threatened preterm labor.

Haas DM, Morgan AM, Deans SJ, Schubert FP.

Cochrane Database Syst Rev. 2015 Nov 5;(11):CD011445. doi: 10.1002/14651858.CD011445.pub2. Review.

PMID:
26544539
20.

Supplemental Content

Support Center